Lucid Diagnostics (LUCD) Competitors $1.00 +0.02 (+2.19%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$1.02 +0.02 (+2.50%) As of 08/1/2025 07:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock LUCD vs. DCTH, TMCI, OM, SNWV, RXST, CLPT, CATX, NNOX, STIM, and NPCEShould you be buying Lucid Diagnostics stock or one of its competitors? The main competitors of Lucid Diagnostics include Delcath Systems (DCTH), Treace Medical Concepts (TMCI), Outset Medical (OM), Sanuwave Health (SNWV), RxSight (RXST), ClearPoint Neuro (CLPT), Perspective Therapeutics (CATX), Nano-X Imaging (NNOX), Neuronetics (STIM), and NeuroPace (NPCE). These companies are all part of the "medical equipment" industry. Lucid Diagnostics vs. Its Competitors Delcath Systems Treace Medical Concepts Outset Medical Sanuwave Health RxSight ClearPoint Neuro Perspective Therapeutics Nano-X Imaging Neuronetics NeuroPace Delcath Systems (NASDAQ:DCTH) and Lucid Diagnostics (NASDAQ:LUCD) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends. Does the media prefer DCTH or LUCD? In the previous week, Lucid Diagnostics had 2 more articles in the media than Delcath Systems. MarketBeat recorded 4 mentions for Lucid Diagnostics and 2 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.77 beat Lucid Diagnostics' score of 0.13 indicating that Delcath Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Delcath Systems 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lucid Diagnostics 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is DCTH or LUCD more profitable? Delcath Systems has a net margin of -26.38% compared to Lucid Diagnostics' net margin of -1,699.86%. Lucid Diagnostics' return on equity of 0.00% beat Delcath Systems' return on equity.Company Net Margins Return on Equity Return on Assets Delcath Systems-26.38% -29.44% -20.75% Lucid Diagnostics -1,699.86%N/A -124.27% Do insiders and institutionals believe in DCTH or LUCD? 61.1% of Delcath Systems shares are owned by institutional investors. Comparatively, 74.0% of Lucid Diagnostics shares are owned by institutional investors. 17.4% of Delcath Systems shares are owned by insiders. Comparatively, 6.8% of Lucid Diagnostics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has higher valuation & earnings, DCTH or LUCD? Delcath Systems has higher revenue and earnings than Lucid Diagnostics. Delcath Systems is trading at a lower price-to-earnings ratio than Lucid Diagnostics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDelcath Systems$37.21M9.91-$26.39M-$0.50-21.18Lucid Diagnostics$4.35M24.87-$45.53M-$1.34-0.75 Which has more risk and volatility, DCTH or LUCD? Delcath Systems has a beta of 0.82, indicating that its share price is 18% less volatile than the S&P 500. Comparatively, Lucid Diagnostics has a beta of 1.21, indicating that its share price is 21% more volatile than the S&P 500. Do analysts recommend DCTH or LUCD? Delcath Systems presently has a consensus target price of $24.00, indicating a potential upside of 126.63%. Lucid Diagnostics has a consensus target price of $3.55, indicating a potential upside of 255.00%. Given Lucid Diagnostics' stronger consensus rating and higher possible upside, analysts plainly believe Lucid Diagnostics is more favorable than Delcath Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Delcath Systems 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00Lucid Diagnostics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 SummaryLucid Diagnostics beats Delcath Systems on 9 of the 16 factors compared between the two stocks. Get Lucid Diagnostics News Delivered to You Automatically Sign up to receive the latest news and ratings for LUCD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LUCD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LUCD vs. The Competition Export to ExcelMetricLucid DiagnosticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$105.87M$6.70B$5.48B$9.54BDividend YieldN/A1.32%4.73%4.09%P/E Ratio-0.7520.9428.8623.83Price / Sales24.8754.12371.7266.14Price / CashN/A20.5035.4557.96Price / Book-1.284.468.275.54Net Income-$45.53M$174.54M$3.25B$259.28M7 Day Performance-9.91%-5.27%-3.74%-4.67%1 Month Performance-4.76%-3.94%4.28%4.37%1 Year Performance33.07%8.26%25.87%17.91% Lucid Diagnostics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LUCDLucid Diagnostics2.7269 of 5 stars$1.00+2.2%$3.55+255.0%+25.0%$105.87M$4.35M-0.7570DCTHDelcath Systems2.7068 of 5 stars$11.41flat$24.00+110.3%+29.3%$397.37M$53.85M-22.8260Upcoming EarningsAnalyst UpgradeTMCITreace Medical Concepts2.4138 of 5 stars$5.75+0.9%$10.52+82.9%-19.0%$358.47M$209.36M-6.76250News CoveragePositive NewsUpcoming EarningsOMOutset Medical1.7102 of 5 stars$18.04-2.6%$29.50+63.5%-71.4%$328.39M$115.27M-0.62520Upcoming EarningsSNWVSanuwave Health2.2821 of 5 stars$35.75-5.6%N/AN/A$324.43M$32.63M-7.8540News CoverageAnalyst ForecastAnalyst RevisionRXSTRxSight3.3687 of 5 stars$7.87-1.3%$17.50+122.4%-82.4%$323.88M$139.93M-11.75220Trending NewsUpcoming EarningsCLPTClearPoint Neuro2.6744 of 5 stars$10.97-2.3%$25.00+127.9%+47.1%$314.32M$31.39M-14.43110Analyst ForecastGap DownCATXPerspective Therapeutics2.3993 of 5 stars$4.12+1.5%$12.56+204.7%-72.5%$305.82MN/A0.0070News CoverageNNOXNano-X Imaging2.3725 of 5 stars$5.14-1.2%$9.50+84.8%-41.1%$300.45M$11.55M-5.71190News CoverageGap DownSTIMNeuronetics1.5458 of 5 stars$4.52+0.7%$5.50+21.7%+148.3%$296.85M$74.89M-3.45180Upcoming EarningsGap DownNPCENeuroPace3.2591 of 5 stars$8.74-2.7%$17.00+94.5%+24.5%$294.53M$79.91M-10.40170News Coverage Related Companies and Tools Related Companies DCTH Alternatives TMCI Alternatives OM Alternatives SNWV Alternatives RXST Alternatives CLPT Alternatives CATX Alternatives NNOX Alternatives STIM Alternatives NPCE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LUCD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lucid Diagnostics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lucid Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LUCD Stock Alerts